HUTCHMED (China) (HCM) EBITDA Margin: 2014-2024

Historic EBITDA Margin for HUTCHMED (China) (HCM) over the last 11 years, with Dec 2024 value amounting to -0.41%.

  • HUTCHMED (China)'s EBITDA Margin rose 45.00% to -0.31% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.84%, marking a year-over-year increase of 674.00%. This contributed to the annual value of -0.41% for FY2024, which is 514.00% down from last year.
  • HUTCHMED (China)'s EBITDA Margin amounted to -0.41% in FY2024, which was down 108.64% from 4.73% recorded in FY2023.
  • Over the past 5 years, HUTCHMED (China)'s EBITDA Margin peaked at 4.73% during FY2023, and registered a low of -92.19% during FY2021.
  • In the last 3 years, HUTCHMED (China)'s EBITDA Margin had a median value of -0.41% in 2024 and averaged 1.23%.
  • Per our database at Business Quant, HUTCHMED (China)'s EBITDA Margin plummeted by 9,415bps in 2021 and then soared by 9,157bps in 2022.
  • Over the past 5 years, HUTCHMED (China)'s EBITDA Margin (Yearly) stood at 1.96% in 2020, then plummeted by 9,415bps to -92.19% in 2021, then spiked by 9,157bps to -0.62% in 2022, then spiked by 535bps to 4.73% in 2023, then slumped by 514bps to -0.41% in 2024.